United Therapeutics Corporation (UTHR) /

The profitability of United Therapeutics Corporation over the past 10 years

Chart United Therapeutics Corporation: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

United Therapeutics Corporation reported net income of $1.33B in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $2.8B and operating income of $1.49B. It reported a profit in 9 of the 10 years shown, and a loss in fiscal 2019.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$2.8B$1.49B$1.33B
2024ended Dec 31, 2024$2.57B$1.38B$1.2B
2023ended Dec 31, 2023$2.07B$1.18B$984.8M
2022ended Dec 31, 2022$1.78B$979.7M$727.3M
2021ended Dec 31, 2021$1.56B$555.9M$475.8M
2020ended Dec 31, 2020$1.38B$593.6M$514.8M
2019ended Dec 31, 2019$1.33B-$187.6M-$104.5M
2018ended Dec 31, 2018$1.43B*$805.4M$589.2M
2017ended Dec 31, 2017$1.62B*$814.9M$417.9M
2016ended Dec 31, 2016$1.53B*$1.06B$713.7M

Fiscal years as United Therapeutics Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on United Therapeutics Corporation

Companies of a similar size

Not investment advice. This page shows what United Therapeutics Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.